<div id="readability-page-1">Sudden stake exit: Berkshire Hathaway sold its entire UnitedHealth position in Q1 2026, less than a year after buying in, prompting a drop in the insurer’s stock. Post-Buffett shift: CEO Greg Abel appears to favor quicker trades and redeploying capital, diverging from Warren Buffett’s long-term holding style. Turnaround continues: Despite the sell-off, UnitedHealth is beating earnings forecasts, investing in AI, and pursuing cost controls to improve profitability.</div>

BRK.B

BRK.A

UNHG

<p>Berkshire Hathaway sold its entire stake in UnitedHealth in Q1 2026, leading to a decline in the insurer's stock. CEO Greg Abel's strategy reflects a shift towards quicker trades, contrasting with Warren Buffett's long-term approach. Despite the sell-off, UnitedHealth is exceeding earnings forecasts and focusing on AI investments and cost controls to enhance profitability.</p>

- Berkshire Hathaway divested its entire UnitedHealth position in Q1 2026, leading to a decline in the insurer's stock.  
- CEO Greg Abel is adopting a strategy of quicker trades and capital redeployment, contrasting with Warren Buffett's long-term investment approach.  
- Despite the sell-off, UnitedHealth is exceeding earnings forecasts and focusing on AI investments and cost controls to enhance profitability.

Unitedhealth

Berkshire Hathaway B

Berkshire Hathaway

VG Health

Health Care Select Sector SPDR

SPDR S&P Health

iShares US Healthcare Providers

Leverage Shares 2X Long UNH Daily ETF

iShares Global Healthcare

Berkshire's UnitedHealth exit sends shares lower despite turnaround